MOG and neuromyelitis optica: The clinical phenotype of disorders with MOG-antibodies far exceeds neuromyelitis optica and includes uni- or bilateral, isolated or recurrent ON, myelitis with or without ON, ADEM [11], brainstem and supra-tentorial lesions [12–14].